As UnitedHealth Group (UNH) prepares for its Q1 2026 earnings report, investor sentiment remains mixed following an earlier jump in stock value from a surprise Medicare Advantage payment hike. Despite a year-to-date decline of nearly 17% due to rising medical costs and regulatory issues, market analysts consider UNH stock potentially undervalued and forecast an 8% decline in earnings per share. Confidence is bolstered by the anticipated raising of its full-year EPS guidance and significant investments in AI initiatives, setting a hopeful outlook amid ongoing Medicare challenges.
Click a month on the chart to update the report below.
